Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.490
+0.002 (0.41%)
Mar 9, 2026, 2:05 PM EDT - Market open
Onconetix Employees
Onconetix had 5 employees as of December 31, 2024. The number of employees decreased by 7 or -58.33% compared to the previous year.
Employees
5
Change (1Y)
-7
Growth (1Y)
-58.33%
Revenue / Employee
$244,750
Profits / Employee
-$10,169,074
Market Cap
761.96K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5 | -7 | -58.33% |
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | 7 | 140.00% |
| Dec 31, 2021 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| Lyra Therapeutics | 30 |
| Aditxt | 26 |
| Virax Biolabs Group | 19 |
| Biodexa Pharmaceuticals | 13 |
| Ensysce Biosciences | 8 |
| CDT Equity | 6 |
| CNS Pharmaceuticals | 5 |
ONCO News
- 23 days ago - Onconetix, Inc. (ONCO) M&A Call Transcript - Seeking Alpha
- 25 days ago - Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company - GlobeNewsWire
- 25 days ago - Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer - Business Wire
- 5 months ago - Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. - GlobeNewsWire
- 5 months ago - Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement - GlobeNewsWire
- 6 months ago - Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM - GlobeNewsWire
- 8 months ago - Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement - GlobeNewsWire
- 9 months ago - Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel - GlobeNewsWire